Point-of-care diagnostics are reshaping how and where patients access healthcare. However, challenges around enzyme stabilization, cost, and logistics can limit their reach.
In this presentation, William Ferreira explores how established and emerging molecular techniques—like qPCR, isothermal amplification, and NGS—can be adapted using ambient-stable reagents to enable rapid, scalable, and cost-effective testing at the point of care. Discover how Meridian’s technologies support the development of assays suitable for clinical labs, pharmacies, and at-home use.
Learn more about our solutions for:
- Molecular point-of-care testing (qPCR, isothermal amplification, and next-generation sequencing)
- Ambient-stable reagent chemistries (lyophilization, cold-chain free)
- Infectious disease diagnostics
- Decentralized testing & rapid assay development
- Scalability in resource-limited or near-patient settings
Register Now! Discover how Meridian’s technologies support the development of assays suitable for clinical labs, pharmacies, and at-home use.
Speaker:
William , R&D Team Leader at Meridian Life Science
William is an R&D Team Leader at Meridian Life Science. He earned his PhD in molecular microbiology in 2019, investigating C. difficile pathogenesis at Royal Holloway, University of London, UK. Subsequently, he held the position of Senior Scientist at Sporegen Ltd, leading diverse research projects rooted in recombinant spore technology. With more than 8 years of expertise in developing molecular assays for clinical use, William is a vital asset within Meridian’s R&D team. His role involves spearheading the creation of cutting-edge molecular products for the global diagnostic industry.
Life Science Webinars in English
视频直播